Safety and Immunogenicity Study of Booster Vaccination in Different Doses of COVID-19 Vaccine (Vero Cell),Inactivated for Prevention of COVID-19
Clinical trial NCT05165966 · COMPLETED
Trial details
- NCT number
- NCT05165966
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-20
- Primary completion
- 2022-04-20
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.